GT Biopharma, Inc.
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2019 | $0.00 | $0.01 |
| FY2020 | $-0.36 | $-0.03 |
| FY2021 | $-0.11 | $-0.05 |
| FY2022 | $-6.55 | $-0.75 |
| FY2023 | $-1.88 | $-0.94 |
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2019 | $0.00 | $0.01 |
| FY2020 | $-0.36 | $-0.03 |
| FY2021 | $-0.11 | $-0.05 |
| FY2022 | $-6.55 | $-0.75 |
| FY2023 | $-1.88 | $-0.94 |